Good morning, everyone. Nice to see you again. The sun is shining here on the Pharmalot corporate campus and we are busy bundling short people off to the school house. And like you, we will be focused on meetings and what-not, but will keep an eye out for interesting items to pass along. Here, in fact, are a few interesting developments. See you later...
Novartis To Invest $1B In China R&D (The Wall Street Journal)
Teva Quarterly Profit Rises (Reuters)
Bristol-Myers, Sanofi Win Plavix Court Ruling (Bloomberg)
Quintiles Ink Clinical Deal With AstraZeneca (OutsourcingPharma)
Crucell Profits Falls 22 Percent (Reuters)
1 Comment
Perhaps I'm the last one to find out, but man, oh man, am I glad you're back, Ed.